We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$5.38B
AUM Growth
+$147M
Cap. Flow
-$94.6M
Cap. Flow %
-1.76%
Top 10 Hldgs %
6.5%
Holding
1,377
New
96
Increased
272
Reduced
312
Closed
117

Top Buys

Rank Stock Value
1
CLR
CONTINENTAL RESOURCES INC.
CLR
+$19.8M
2
TMO icon
Thermo Fisher Scientific
TMO
+$16.5M
3
RHI icon
Robert Half
RHI
+$16.3M
4
AMGN icon
Amgen
AMGN
+$16.1M
5
KMB icon
Kimberly-Clark
KMB
+$15.4M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$24M
2
CAR icon
Avis
CAR
+$19.1M
3
PSA icon
Public Storage
PSA
+$19M
4
WMT icon
Walmart Inc
WMT
+$17.9M
5
MS icon
Morgan Stanley
MS
+$17.3M

Sector Composition

Rank Sector Weight
1 Financials 26.23%
2 Industrials 11.79%
3 Consumer Discretionary 11.71%
4 Technology 10.81%
5 Healthcare 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDSX icon
951
Biodesix
BDSX
$248M
$555K 0.01%
+5,250
New +$686K
DMRA
952
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.84B
$555K 0.01%
7,324
-4,000
-35% -$314K
SYRS
953
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$554K 0.01%
+17,000
New +$688K
SGTX
954
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$552K 0.01%
+15,385
New +$876K
PBIP
955
DELISTED
Prudential Bancorp, Inc.
PBIP
$551K 0.01%
40,557
– –
ARCH
956
DELISTED
Arch Resources, Inc.
ARCH
$548K 0.01%
6,000
– –
KRO icon
957
KRONOS Worldwide
KRO
$989M
$546K 0.01%
36,400
– –
GHM icon
958
Graham Corp
GHM
$1.31B
$545K 0.01%
43,800
– –
JAKK icon
959
Jakks Pacific
JAKK
$293M
$544K 0.01%
53,590
+8,720
+19% +$97.5K
CRVS icon
960
Corvus Pharmaceuticals
CRVS
$1.17B
$541K 0.01%
224,300
+65,000
+41% +$252K
CYPH
961
Cypherpunk Technologies Inc
CYPH
$73.3M
$541K 0.01%
16,710
-8,000
-32% -$222K
SUP
962
DELISTED
Superior Industries International
SUP
$538K 0.01%
120,200
-23,700
-16% -$125K
WDFC icon
963
WD-40
WDFC
$3.15B
$538K 0.01%
2,200
– –
ATNM icon
964
Actinium Pharmaceuticals
ATNM
$25M
$535K 0.01%
88,966
+9,800
+12% +$73.5K
LXRX icon
965
Lexicon Pharmaceuticals
LXRX
$1.1B
$534K 0.01%
135,500
-244,592
-64% -$1.19M
DBTX
966
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$534K 0.01%
114,928
– –
CIZN
967
DELISTED
Citizens Holding Co.
CIZN
$534K 0.01%
28,470
– –
LCTX icon
968
Lineage Cell Therapeutics
LCTX
$274M
$532K 0.01%
217,266
-11,000
-5% -$25.7K
INZY
969
DELISTED
Inozyme Pharma
INZY
$528K 0.01%
+77,400
New +$669K
ACCS
970
ACCESS Newswire
ACCS
$26.2M
$527K 0.01%
17,900
– –
BBQ
971
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$525K 0.01%
33,038
– –
IDN icon
972
Intellicheck
IDN
$79.6M
$523K 0.01%
113,300
+50,000
+79% +$344K
GFED
973
DELISTED
Guaranty Federal Bancshares In
GFED
$522K 0.01%
16,356
– –
INFU icon
974
InfuSystem Holdings
INFU
$249M
$519K 0.01%
+30,473
New +$483K
LMB icon
975
Limbach Holdings
LMB
$581M
$519K 0.01%
57,700
-29,800
-34% -$219K
37 38
39
40 41

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Bridgeway Capital Management held 1,377 positions worth $5.38B, up 2.8% from $5.23B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

Bridgeway Capital Management's Q4 2021 filing shows 96 new, 272 increased, 312 reduced and 117 closed positions. Its largest new stake was CONTINENTAL RESOURCES INC.: 416,650 shares worth $18.6M. The largest sale was PepsiCo, an estimated $24M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Bridgeway Capital Management's largest Q4 2021 buy was CONTINENTAL RESOURCES INC.: 416,650 shares worth $18.6M.
  • Bridgeway Capital Management added most to Thermo Fisher Scientific in Q4 2021, an estimated $16.5M increase.
  • Bridgeway Capital Management's biggest Q4 2021 reduction was PepsiCo, cutting an estimated $24M.
  • Bridgeway Capital Management fully exited Public Storage in Q4 2021, selling an estimated $19M.
  • Bridgeway Capital Management's ten largest holdings make up 6.5% of its $5.38B portfolio in Q4 2021.
  • Bridgeway Capital Management opened 96 new positions and closed 117 in Q4 2021.
  • Bridgeway Capital Management's portfolio value rose 2.8% quarter-over-quarter to $5.38B.

Based on Bridgeway Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.